Pre-close Trading Update

Oxford Instruments PLC
04 April 2008


4 April 2008

Oxford Instruments plc
Pre-close Trading Update

Oxford Instruments plc ("Oxford Instruments" or "the Group"), the advanced
instrumentation company, is today issuing a trading statement ahead of entering
its close period.

The Board is confident that the Group's full year performance is in line with
expectations.

Oxford Instruments' preliminary results for the year ended 31st March 2008 will
be released on Tuesday 10 June.

Ends

Enquiries:

Oxford Instruments plc             Tel: [phone]
Jonathan Flint Chief Executive
Kevin Boyd Group Finance Director

Hogarth Partnership                Tel: [phone]
Rachel Hirst
Andrew Jaques

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools,
processes and solutions with a focus on physical science, bioscience,
environmental and industrial research and applications. It provides solutions
needed to advance fundamental nanoscience research and its transfer into
commercial nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 40 years, and its
strategy is to effect the successful commercialisation of these ideas by
bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University over forty
years ago, Oxford Instruments is now a global company with over 1,300 staff
worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to
be the leading provider of new generation tools and systems for the Physical
Science and Bioscience sectors.

This involves the combination of core technologies in areas such as low
temperature and high magnetic field environments, Nuclear Magnetic Resonance,
X-ray electron and optical based metrology, and advanced growth, deposition and
etching. Our products, expertise, and ideas address global issues such as
energy, environment, terrorism and health and are part of the next generation of
telecommunications, energy products, environmental measures, security devices,
drug discovery and medical advances.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
              BKDPQK